Awarded contract

Covid-19: DHSC: NHSX - Remote Symptoms Tracking System, App and supply of SpO2 Devices

  • Department of Health and Social Care

F03: Contract award notice

Notice reference: 2021/S 000-004532

Published 6 March 2021, 10:17am



Section one: Contracting authority

one.1) Name and addresses

Department of Health and Social Care

39 Victoria Street

London

SW1H 0EU

Contact

Sachin Joshi

Email

sachin.joshi@dhsc.gov.uk

Country

United Kingdom

NUTS code

UKI32 - Westminster

Internet address(es)

Main address

https://www.gov.uk/government/organisations/department-of-health-and-social-care

Buyer's address

https://www.gov.uk/government/organisations/department-of-health-and-social-care

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Covid-19: DHSC: NHSX - Remote Symptoms Tracking System, App and supply of SpO2 Devices

Reference number

C25022

two.1.2) Main CPV code

  • 33195000 - Patient-monitoring system

two.1.3) Type of contract

Supplies

two.1.4) Short description

This procurement was awarded in April 2020 for access to the "Medopad software as a service and Application" for a pilot in two London NHS Trusts.The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20/04/20 to 31/12/20 inclusive. However, DHSC had to purchase 20,000 Pulse Oximeters at pace to allocate to the Pilot's patients, and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £282,218.15

two.2) Description

two.2.2) Additional CPV code(s)

  • 48180000 - Medical software package

two.2.3) Place of performance

NUTS codes
  • UKI - LONDON
Main site or place of performance

London

two.2.4) Description of the procurement

A programme to deploy remote monitoring of COVID patientsNHSX was reviewing the deployment of remote monitoring to ensure that patients have access to medical care during the Covid19 pandemic. Medopad (owned by Huma Therapeutics Ltd) is a remote monitoring product that had completed the Digital Health London accelerator, and had approached NHSX (following the national call for innovator assistance) following their similar work with other EU governments, as part of their Covid19 response. The two use cases is for this programme of work were to perform daily monitoring on the Covid-19 patients that had been recently discharged from hospital and provide an electronic monitoring of potential Covid-19 patients who were routed through primary care hot hubs. Both use cases allowed the early identification of deterioration of patients and ensure that health professionals could intervene before their patients found it difficult to breath and had long lasting damage to their lungs. This procurement was for access to the "Medopad software as a service and Application" for a pilot in two London NHS Trusts.The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20/04/20 to 31/12/20 inclusive. However, DHSC had to purchase 20,000 Pulse Oximeters at pace to allocate to the Pilot's patients and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification..

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

A copy of the redacted contract is provided at the following linkhttps://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kHb2/6dYIxgutqoH6wT7FRGhuKv.vO33BHUY6PZLTFcQmoqA


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The products involved are manufactured purely for the purpose of research, experiment, study or development
  • Extreme urgency brought about by events unforeseeable for the contracting authority

Explanation:

The Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 Mar 2020.COVID-19 is serious and its consequences pose a risk to life. Cabinet Office published PPN 01/20: Responding to COVID-19 on procuring with extreme urgency in March 2020 which states that contracting authorities may enter into contracts withoutcompeting or advertising the requirement where certain tests are met.1) There are genuine reasons for extreme urgency as there is a significant public health risk requiring immediate action as a result of COVID-19 2) The COVID-19 situation is novel and the Contracting Authority could not have reasonably foreseen these events3) It is not possible to comply with the timescales of another procedure due to the urgent requirement to obtain the [supplies] being contracted for. Additionally, there are many buyers competing for the same supplies. It is imperative that security of supply is maintained. Demand for equipment is high and there is little or no incentive for suppliers to participate in competitive procurement procedures. 4) The situation is not attributable to the contracting authority]This procurement was awarded in April 2020 for access to the "Medopad software as a service and Application" for a pilot in two London NHS Trusts. The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20/04/20 to 31/12/20 inclusive. However, DHSC had to purchase 20,000 Pulse Oximeters at pace to allocate to the Pilot's patients, and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

17 April 2020

five.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from other EU Member States: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Huma Therapeutics Limited

13th Floor, Millbank Tower, 21-21 Millbank, Westminster,

London

SW1P 4QP

Country

United Kingdom

NUTS code
  • UKI3 - Inner London – West
National registration number

07725451

Internet address

https://huma.com/

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £282,218.15

Total value of the contract/lot: £282,218


Section six. Complementary information

six.3) Additional information

A copy of the redacted contract is provided at the following linkhttps://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kHb2/6dYIxgutqoH6wT7FRGhuKv.vO33BHUY6PZLTFcQmoqA

six.4) Procedures for review

six.4.1) Review body

High Court

39 Victoria Street

London

SW1H 0EU

Country

United Kingdom

Internet address

https://www.gov.uk/government/organisations/department-of-health-and-social-care

six.4.2) Body responsible for mediation procedures

High Court

39 Victoria Street

London

SW1H 0EU

Country

United Kingdom

Internet address

https://www.gov.uk/government/organisations/department-of-health-and-social-care

six.4.4) Service from which information about the review procedure may be obtained

Department of Health and Social Care

39 Victoria Street

London

SW1H 0EU

Country

United Kingdom

Internet address

https://www.gov.uk/government/organisations/department-of-health-and-social-care